B6J.129S2-Nr2c2tm1.1Ics/Ics

Status

Available to order

EMMA IDEM:12958
International strain nameB6J.129S2-Nr2c2tm1.1Ics/Ics
Alternative nameTR4 CM
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolNr2c2tm1.1Ics
Gene/Transgene symbolNr2c2

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationFor detailed information on the genetic description of this strain, please have a look at this report.
Phenotypic informationHomozygous:
NA

Heterozygous:
NA
Breeding history8 backcross generations
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • impaired glucose tolerance / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
  • embryonic lethality prior to tooth bud stage / IMPC
MGI phenotypes (gene matching)
  • decreased circulating LDL cholesterol level / MGI
  • seminiferous tubule degeneration / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • abnormal eating behavior / MGI
  • abnormal hemoglobin / MGI
  • decreased inflammatory response / MGI
  • reduced male fertility / MGI
  • abnormal glucose homeostasis / MGI
  • abnormal lipid homeostasis / MGI
  • decreased susceptibility to hepatic steatosis / MGI
  • decreased circulating triglyceride level / MGI
  • oligozoospermia / MGI
  • decreased circulating insulin level / MGI
  • decreased circulating alanine transaminase level / MGI
  • abnormal gas homeostasis / MGI
  • decreased testis weight / MGI
  • increased energy expenditure / MGI
  • decreased circulating cholesterol level / MGI
  • increased oxygen consumption / MGI
  • abnormal energy homeostasis / MGI
  • decreased circulating glucose level / MGI
  • decreased circulating aspartate transaminase level / MGI
  • decreased susceptibility to diet-induced obesity / MGI
  • abnormal white adipose tissue physiology / MGI
  • arrest of male meiosis / MGI
  • increased carbon dioxide production / MGI
  • decreased white fat cell size / MGI
  • decreased abdominal fat pad weight / MGI
  • decreased epididymal fat pad weight / MGI
  • decreased liver triglyceride level / MGI
  • abnormal blood homeostasis / MGI
  • increased respiratory quotient / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • decreased body fat mass / MGI
  • decreased brown adipose tissue mass / MGI
  • multinucleated giant male germ cells / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).